Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Y 24180

Known as: Y-24180 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
To examine the effects of acid exposure on the adherence of Streptococcus pneumoniae to cultured human tracheal epithelial cells… Expand
2001
2001
To evaluate the effect of Y-24180, a potent and long-acting antagonist to platelet-activating factor (PAF) receptors, on… Expand
Highly Cited
1999
Highly Cited
1999
Eosinophil activation and subsequent release of inflammatory mediators are implicated in the pathophysiology of allergic diseases… Expand
1999
1999
We examined the effects of Y-24180, a potent and long-acting antagonist to platelet-activating factor (PAF), on allergic… Expand
1998
1998
Abstract.Objective and Design: We examined the effect of Y-24180, a potent platelet-activating factor (PAF) antagonist, on IgE… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1997
1997
Abstract.Objective and Design: Effects of Y-24180 on antigen-induced asthmatic responses were evaluated in actively sensitized… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
1996
Highly Cited
1996
Oxygen radicals produced by activated neutrophils have been involved in brain injury during ischemia-reperfusion. Platelet… Expand
Highly Cited
1995
Highly Cited
1995
The involvement of platelet-activating factor (PAF) in bronchial hyperresponsiveness (BHR) in bronchial asthma has been… Expand
1990
1990
The ability of Y-24180, 4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]- 6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a] [1… Expand
1990
1990
The inhibitory effect of Y-24180, 4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-t hieno [3,2-f][1,2,4]triazolo… Expand